# HCW Biologics Inc.: Form 8-K, filed Jun 1, 2026

- Company: [HCW Biologics Inc.](/companies/hcwb.md) (CIK 1828673)
- Form: 8-K
- Filed: 2026-06-01
- Accepted by EDGAR: Jun 1, 2026, 07:30 ET
- Period: 2026-05-29
- Accession: 0001493152-26-026529
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/form8-k.htm

Filed Jun 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-026529. Last ingested by Listed: Nov 5, 2026, 12:33 ET. No prices; not investment advice.